bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
5.05
-0.04 (-0.79%)
Aug 27, 2026, 2:26 PM EDT - Market open
bioAffinity Technologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.43 | 6.45 | 1.11 | 2.82 | 11.41 | 1.36 |
Cash & Short-Term Investments | 2.43 | 6.45 | 1.11 | 2.82 | 11.41 | 1.36 |
Cash Growth | 202.64% | 483.54% | -60.83% | -75.28% | 738.85% | 1537.19% |
Accounts Receivable | 0.88 | 0.52 | 1.11 | 0.78 | - | 0 |
Other Receivables | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | - |
Receivables | 0.89 | 0.54 | 1.14 | 0.81 | 0.01 | 0 |
Inventory | 0.08 | 0.05 | 0.03 | 0.02 | 0.01 | - |
Prepaid Expenses | 0.14 | 0.23 | 0.25 | 0.17 | 0.34 | 0.02 |
Other Current Assets | 0.32 | 0.29 | 0.17 | 0.15 | 0.19 | 0.06 |
Total Current Assets | 3.87 | 7.57 | 2.7 | 3.97 | 11.96 | 1.44 |
Property, Plant & Equipment | 1.65 | 1.26 | 1.62 | 1.99 | 0.21 | 0 |
Goodwill | 1.4 | 1.4 | 1.4 | 1.4 | - | - |
Other Intangible Assets | 0.69 | 0.72 | 0.78 | 0.83 | - | - |
Long-Term Deferred Charges | - | - | - | - | - | 0.01 |
Other Long-Term Assets | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0 |
Total Assets | 7.62 | 10.96 | 6.51 | 8.22 | 12.18 | 1.45 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.97 | 0.76 | 0.99 | 0.6 | 0.35 | 0.23 |
Accrued Expenses | 1.41 | 1.72 | 1.4 | 1.15 | 0.54 | 1.6 |
Short-Term Debt | - | - | - | - | 0.25 | 11.15 |
Current Portion of Long-Term Debt | 0.02 | 0.11 | 0.17 | - | - | 0.05 |
Current Portion of Leases | 0.24 | 0.28 | 0.52 | 0.46 | - | - |
Current Unearned Revenue | 0.03 | 0.04 | 0.02 | 0.03 | - | - |
Total Current Liabilities | 2.68 | 2.91 | 3.1 | 2.25 | 1.14 | 13.04 |
Long-Term Debt | 0.04 | 0.04 | 0.02 | - | - | 0.16 |
Long-Term Leases | 1.13 | 0.74 | 0.79 | 1.12 | - | - |
Total Liabilities | 3.85 | 3.68 | 3.91 | 3.37 | 1.14 | 13.2 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.03 | 0 | 0.07 | 0.06 | 0.02 |
Additional Paid-In Capital | 79.27 | 75.8 | 56.24 | 49.39 | 47.65 | 12.7 |
Retained Earnings | -75.55 | -68.55 | -53.64 | -44.6 | -36.67 | -28.51 |
Total Common Equity | 3.77 | 7.28 | 2.6 | 4.86 | 11.04 | -15.79 |
Shareholders' Equity | 3.77 | 7.28 | 2.6 | 4.86 | 11.04 | -11.75 |
Total Liabilities & Equity | 7.62 | 10.96 | 6.51 | 8.22 | 12.18 | 1.45 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.44 | 1.16 | 1.5 | 1.58 | 0.25 | 11.36 |
Net Cash (Debt) | 0.99 | 5.29 | -0.4 | 1.24 | 11.16 | -10 |
Net Cash Growth | 648.82% | - | - | -88.87% | - | - |
Net Cash Per Share | 3.91 | 46.10 | -14.69 | 63.94 | - | - |
Filing Date Shares Outstanding | 0.54 | 0.3 | 0.04 | 0.03 | 0.02 | - |
Total Common Shares Outstanding | 0.45 | 0.3 | 0.03 | 0.02 | 0.02 | - |
Working Capital | 1.18 | 4.66 | -0.41 | 1.72 | 10.82 | -11.6 |
Book Value Per Share | 8.34 | 24.29 | 76.89 | 232.56 | 592.94 | - |
Tangible Book Value | 1.68 | 5.16 | 0.42 | 2.62 | 11.04 | -15.79 |
Tangible Book Value Per Share | 3.71 | 17.21 | 12.48 | 125.37 | 592.94 | - |
Machinery | 0.91 | 0.94 | 0.89 | 0.82 | 0.48 | 0.26 |
Leasehold Improvements | 0.1 | 0.03 | 0.02 | 0.01 | - | - |